| Source NDC Code |
|
Target HCPCS Code |
00069-0249-01
RUXIENCE 500 MG/50 ML VIAL
|
⇄
|
Q5119
Inj, rituximab-pvvr, biosimilar, (ruxience), 10 mg
|
| Detail Information |
| Relationship Start Date |
07/01/2020 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
00069-0249-01
Ruxience
|
⇄
|
Q5119
Inj ruxience, 10 mg
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|